On July 20, 2023, Chiome Bioscience Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
123 JPY | 0.00% | -3.15% | -8.89% |
Apr. 01 | Chiome Bioscience Cancels License Agreements with ADC Therapeutics | MT |
Feb. 13 | Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited | CI |
1st Jan change | Capi. | |
---|---|---|
-8.89% | 43.53M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 4583 Stock
- News Chiome Bioscience Inc.
- Chiome Bioscience Inc. announced that it has received ¥13.49304 million in funding from Barclays Bank PLC (Tokyo Branch), Growth Capital, Inc.